Repository logo
 

A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.

Accepted version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/315175

Repository DOI

https://doi.org/10.17863/CAM.62283

Files

Accepted version (1.9 MB)

Type

Conference Object

Change log

Authors

Millstein, Joshua 
Budden, Timothy 
Anglesio, Michael 
Talhouk, Aline 
Beeghly-Fadiel, Alicia 
Show 5 more

Description

Keywords

32 Biomedical and Clinical Sciences, 3211 Oncology and Carcinogenesis, Women's Health, Ovarian Cancer, Cancer, Genetics, Clinical Research, Rare Diseases, Orphan Drug, 4.4 Population screening, Cancer

Journal Title

JOURNAL OF CLINICAL ONCOLOGY

Conference Name

Journal ISSN

0732-183X
1527-7755

Volume Title

36

Publisher

American Society of Clinical Oncology (ASCO)

Publisher DOI

https://doi.org/10.1200/JCO.2018.36.15_suppl.5583

Rights

All rights reserved
Sponsorship
Cancer Research Uk (None)
National Institutes of Health (NIH) (via H Lee Moffitt Cancer Center & Research Institute) (SUBAWARD # 10-15915-01-03-G2)
Congressionally Directed Medical Research Programs (CDMRP) (via (BD521555)
National Institutes of Health (NIH) (via Cedars-Sinai Medical Center) (sub award 0001331845)
H. Lee Moffitt Cancer Center & Research Institute (8604)

Collections

University of Cambridge Research Outputs (Articles and Conferences)